CD14 and rheumatoid arthritis: Besides, we have characterized the molecular profile of CD14+ and CD16+ monocyte subsets in RA, including the identification of their genetic and epigenetic profiles related to atherogenesis and cardiovascular risk and the activated intracellular pathways that modulate those proinflammatory and prothrombotic alterations.